VA NEPHRON-D
2013
Veterans Affairs Nephropathy in Diabetes
In 1,448 patients with type 2 diabetes and albuminuric CKD, dual blockade with losartan plus lisinopril did not reduce the renal composite compared with losartan alone.
Result
Efficacy: eGFR decline, ESRD or deathHR 0.88 (95% CI 0.70-1.12) · P = 0.30
Safety: HyperkalaemiaHR 2.8 · P < 0.001
Below 1 favours dual blockade with losartan plus lisinopril, above 1 favours losartan alone.
- Subtopic
- RAAS blockade
- Design
- Double-blind RCT, stopped early for safety
- Relevance
- Important: one of several pillars.
- Source
- Fried LF, et al. N Engl J Med. 2013;369(20):1892-1903.doi 10.1056/NEJMoa1303154
Discussion & critique
Definitive end to dual RAS blockade; KDIGO explicitly recommends against it.